Tuesday, 19 April 2022

J&J lowers 2022 revenue and earnings expectations, stops giving Covid vaccine sales guidance

When asked about halting guidance for J&J's Covid vaccine, CFO Joe Wolk said the shots are not for profit and do not impact the company's bottom line.

from Earnings https://ift.tt/n32NOov
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)